1. OP0167 Efficacy and safety of CNTX-4975 in subjects with moderate to severe osteoarthritis knee pain: 24-week, randomized, double-blind, placebo-controlled, dose-ranging study. (15th June 2017) Authors: Stevens, R; Petersen, D; Ervin, J; Nezzer, J; Nieves, Y; Campbell, J; Guedes, K; Burges, R; Hanson, P Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 121 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗